Search for Clinical Trial Results
Carcinoma, Medullary - 25 Studies Found
Status | Study |
Recruiting |
Study Name: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Condition:
|
Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition:
|
Recruiting |
Study Name: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer Condition:
|
Completed |
Study Name: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Condition:
|
Completed |
Study Name: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors Condition:
|
Active, not recruiting |
Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Condition:
|
Completed |
Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Condition:
|
Completed |
Study Name: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer Condition:
|
Completed |
Study Name: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Condition:
|